Andrew K Lee

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy
    Andrew K Lee
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:456-62. 2005
  2. ncbi Radiation therapy combined with hormone therapy for prostate cancer
    Andrew K Lee
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Semin Radiat Oncol 16:20-8. 2006
  3. ncbi Update on radiation therapy in prostate cancer
    Andrew K Lee
    Division of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Hematol Oncol Clin North Am 20:857-78. 2006
  4. ncbi Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy
    Andrew K Lee
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1202, Houston, TX 77030 4009, USA
    J Clin Oncol 23:8192-7. 2005
  5. ncbi Appropriate use of nomograms to guide prostate cancer treatment selection
    Andrew K Lee
    Department of Radiation Oncology, M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    J Natl Compr Canc Netw 8:201-9. 2010
  6. ncbi Using prostate-specific antigen doubling time in clinical practice
    Andrew K Lee
    University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    BJU Int 100:243-4. 2007
  7. ncbi Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
    Andrew K Lee
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
    Urol Oncol 21:123-7. 2003
  8. ncbi Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer
    Renaud de Crevoisier
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1529-36. 2007
  9. ncbi Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy
    Jennifer C O'Daniel
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:274-80. 2008
  10. ncbi Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy
    Lei Dong
    Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 66:883-91. 2006

Detail Information

Publications69

  1. ncbi Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy
    Andrew K Lee
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:456-62. 2005
    ..To determine whether prostate-specific antigen (PSA) doubling time predicts clinical outcomes in patients with prostate cancer that has been treated with combined radiation and hormone therapy...
  2. ncbi Radiation therapy combined with hormone therapy for prostate cancer
    Andrew K Lee
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Semin Radiat Oncol 16:20-8. 2006
    ..This review will summarize trials using hormonal therapy and radiation with an emphasis on phase III studies and describe the more recent integration of hormone therapy with radiation for prostate cancer...
  3. ncbi Update on radiation therapy in prostate cancer
    Andrew K Lee
    Division of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Hematol Oncol Clin North Am 20:857-78. 2006
    ....
  4. ncbi Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy
    Andrew K Lee
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1202, Houston, TX 77030 4009, USA
    J Clin Oncol 23:8192-7. 2005
    ....
  5. ncbi Appropriate use of nomograms to guide prostate cancer treatment selection
    Andrew K Lee
    Department of Radiation Oncology, M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    J Natl Compr Canc Netw 8:201-9. 2010
    ..Clinicians and patients should still exercise due diligence when interpreting the results of these nomograms, and these prediction tools should not serve as a stand-alone substitute for clinical decision-making...
  6. ncbi Using prostate-specific antigen doubling time in clinical practice
    Andrew K Lee
    University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    BJU Int 100:243-4. 2007
  7. ncbi Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
    Andrew K Lee
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
    Urol Oncol 21:123-7. 2003
    ..Further studies are needed in order to delineate which patients may not benefit from treatment...
  8. ncbi Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer
    Renaud de Crevoisier
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1529-36. 2007
    ..To quantify the three-dimensional variations of pelvic anatomy after a single treatment fraction...
  9. ncbi Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy
    Jennifer C O'Daniel
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:274-80. 2008
    ....
  10. ncbi Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy
    Lei Dong
    Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 66:883-91. 2006
    ..CT-guided alignment provided the best and most consistent dosimetric coverage. A larger planning target volume margin is needed for SV coverage when the alignment target is the prostate...
  11. ncbi Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?
    Michelle M Kim
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 97, Houston, TX 77030 4009, USA
    Eur J Cancer 48:1664-71. 2012
    ....
  12. ncbi Quantification of prostate and seminal vesicle interfraction variation during IMRT
    Steven J Frank
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:813-20. 2008
    ....
  13. ncbi PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era
    Sean E McGuire
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Int J Radiat Oncol Biol Phys 85:e39-46. 2013
    ....
  14. ncbi Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?
    Katherine O Castle
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 85:693-9. 2013
    ....
  15. ncbi Improvement in prostate cancer survival over time: a 20-year analysis
    Michelle M Kim
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009 USA
    Cancer J 18:1-8. 2012
    ..This study aimed to evaluate the changes in outcome for men with localized prostate cancer treated with definitive external beam radiation therapy during a 20-year period at a comprehensive cancer center...
  16. ncbi Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment
    Xiaodong Zhang
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 67:620-9. 2007
    ..To determine the dosimetric impact of interfraction anatomic movements in prostate cancer patients receiving proton therapy...
  17. ncbi Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy
    Rex Cheung
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:134-40. 2005
    ..By comparing the outcomes for patients who received RT alone and for those who received combined RT and hormonal therapy, we assessed the potential benefits of hormonal therapy...
  18. ncbi Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate
    Christine M Fisher
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Brachytherapy 11:429-34. 2012
    ..The purpose of this study was to evaluate long-term outcomes for men with early stage prostate cancer treated with radical prostatectomy (RP) or brachytherapy (BT) at a single tertiary care center...
  19. ncbi Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
    Adam D Melancon
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, USA
    Radiother Oncol 85:251-9. 2007
    ....
  20. ncbi A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment
    Enzhuo M Quan
    Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 83:1169-78. 2012
    ..We performed a comprehensive comparative study of the plan quality between volumetric-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT) for the treatment of prostate cancer...
  21. ncbi Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 70:67-74. 2008
    ..To report the long-term results of a randomized radiotherapy dose escalation trial for prostate cancer...
  22. ncbi Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model
    Susan L Tucker
    Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
    Int J Radiat Oncol Biol Phys 78:1253-60. 2010
    ....
  23. ncbi Effectiveness of using fewer implanted fiducial markers for prostate target alignment
    Rajat J Kudchadker
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 74:1283-9. 2009
    ..To evaluate the impact of the number and location of intraprostatic fiducial markers on the accuracy and reproducibility of daily prostate target alignment and to evaluate the migration of such markers...
  24. ncbi Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy
    Steven J Frank
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    J Urol 181:1658-63; discussion 1663-4. 2009
    ..We examined whether the Prostogram accurately predicted recurrence at 5 years in patients treated with (125)I brachytherapy at 1 tertiary cancer center...
  25. ncbi Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 79:1310-7. 2011
    ..To report long-term failure patterns and survival in a randomized radiotherapy dose escalation trial for prostate cancer...
  26. ncbi An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer
    Laurence E Court
    Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:154-63. 2005
    ....
  27. ncbi A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy
    Steven J Frank
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Clin Oncol 33:173-5. 2010
    ....
  28. ncbi Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer
    M Rex Cheung
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 67:1059-65. 2007
    ..We sought to identify the bladder dose-volume factors associated with an increased risk of late urinary toxicity among prostate cancer patients treated with radiotherapy...
  29. ncbi Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer
    Sara S Strom
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:631-9. 2006
    ..The current study sought to determine whether obesity was an independent predictor of biochemical failure (BF) and clinical recurrence (CF) among patients treated with external-beam radiotherapy (EBRT)...
  30. ncbi Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
    Philippe E Spiess
    Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 107:275-80. 2006
    ..The statistically significant difference in pre- and postsalvage cryotherapy PSA DTs was reflective of aggressive tumor biology...
  31. ncbi Comparison of treatment volumes and techniques in prostate cancer radiation therapy
    Catherine T Lee
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Am J Clin Oncol 28:618-25. 2005
    ..Because dose-volume parameters have been shown to relate to toxicity, IMRT would appear to be the favored technique for prostate cancer radiation, particularly with regard to nodal treatment...
  32. ncbi Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans
    Samir V Sejpal
    Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 75:40-8. 2009
    ..To evaluate the dose changes to the target and critical structures from rotational setup errors in prostate cancer patients treated with proton therapy...
  33. ncbi Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
    Rajat J Kudchadker
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 72:623-7. 2008
    ..To characterize the amount of activity required to treat the prostate with stranded (125)I radioactive seeds and compare our stranded data with the amount of activity recommended when individual seeds are implanted using a Mick applicator...
  34. ncbi Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature
    Paul L Nguyen
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 110:1417-28. 2007
    ....
  35. ncbi An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer
    Steven J Frank
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 177:2151-6; discussion 2156. 2007
    ..Monotherapy with radical prostatectomy, high dose external beam radiotherapy or a (125)I implant is reported to produce equivalent outcomes. We assessed the health related quality of life associated with these 3 treatment approaches...
  36. ncbi Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer
    Jonas D Fontenot
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Int J Radiat Oncol Biol Phys 74:616-22. 2009
    ....
  37. ncbi Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure
    Ashish M Kamat
    Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 63:1132-7. 2004
    ..CONCLUSIONS: A PSA increase of 1.5 ng/mL or more above the 24-month nadir can be used to predict for ASTRO-defined failure after EBRT and may be used to identify patients at risk early-on...
  38. ncbi Symptomatic local recurrence of prostate carcinoma after radiation therapy
    Dan Leibovici
    Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:2060-6. 2005
    ..Aggressive histologic subtypes were predictive of this endpoint. Clinical T classification, Gleason score, and initial prostate-specific antigen levels also may have predictive value...
  39. ncbi Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance
    Heng Li
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030
    Med Phys 40:021703. 2013
    ..The analysis tool developed here could be useful for assessing spot position uncertainty and thus dose uncertainty for any patient receiving spot scanning proton beam therapy...
  40. ncbi Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate
    Jessie Y Huang
    The University of Texas at Houston Graduate School of Biomedical Sciences, 6767 Bertner Avenue, S3 8344, Houston, TX 77030, USA
    Phys Med Biol 56:5287-302. 2011
    ..Based on the results, three fiducials were identified as good candidates for use in proton radiotherapy of prostate cancer...
  41. ncbi Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?
    Philippe E Spiess
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Urol Oncol 26:25-30. 2008
    ..To assess the use of several preoperative parameters in predicting the side of pelvic lymph node metastasis in patients with prostate cancer...
  42. ncbi Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?
    Patrick W Linson
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02215, USA
    Urology 59:704-8. 2002
    ....
  43. ncbi Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer
    Joey Cheung
    The University of Texas at Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA
    Phys Med Biol 55:7135-47. 2010
    ..This suggests that carbon-coated and stainless steel fiducials could be used in proton therapy if they are located far from the end of the range of the beam and if they are oriented perpendicular to the beam axis...
  44. ncbi Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer
    Phillip J Taddei
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 94, Houston, TX 77030, USA
    Phys Med Biol 53:2131-47. 2008
    ....
  45. ncbi Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma
    Charles J Rosser
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1-6. 2003
    ....
  46. ncbi Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy
    Thomas J Pugh
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Electronic address
    Brachytherapy 12:204-9. 2013
    ..To determine the ability of endorectal magnetic resonance imaging (erMRI) and other pretreatment factors to predict the presence and extent of extraprostatic extension (EPE) in men with Gleason score (GS) 7 prostate cancer...
  47. ncbi Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?
    Charles J Rosser
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 66:327-31. 2005
    ..To evaluate the effect of patient age on the occurrence of prostate-specific antigen (PSA) "bounce" after external beam radiotherapy (EBRT) for prostate cancer...
  48. ncbi Toxicity associated with postoperative radiation therapy for prostate cancer
    Puneeth Iyengar
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    Am J Clin Oncol 34:611-8. 2011
    ..To quantify gastrointestinal (GI) and genitourinary (GU) toxicity associated with postprostatectomy radiation and to determine the relationships between dosimetry parameters and medical comorbidities and toxicity...
  49. ncbi Role of radiation therapy for the treatment of lymph nodes in urologic malignancies
    Thomas J Pugh
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1840 Old Spanish Trail, Unit 0097, Houston, TX 77054, USA
    Urol Clin North Am 38:497-506, vii. 2011
    ..This article provides an overview of the modalities, indications, and techniques of RT for treatment of the lymphatic basins in GU malignancies...
  50. ncbi Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study
    Laurence E Court
    Department of Radiation Physics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Int J Radiat Oncol Biol Phys 59:412-8. 2004
    ..The use of a reference image is important to improve the consistency among different users in this technique...
  51. ncbi Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy
    Rex Cheung
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 61:993-1002. 2005
    ..We also investigated the differences in the dose-response characteristics using the American Society for Therapeutic Radiology and Oncology (ASTRO) definition vs. an alternative biochemical failure definition...
  52. ncbi Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience
    John F Anderson
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 74:601-5. 2009
    ..To minimize the risk of long-term urinary morbidity, it is important for clinicians to be able to distinguish acute urinary side effects after prostate brachytherapy from longer-term treatment-related urinary complications...
  53. ncbi Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose
    X Ronald Zhu
    Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 81:552-9. 2011
    ..To describe our experiences with patient-specific quality assurance (QA) for patients with prostate cancer receiving spot scanning proton therapy (SSPT) using single-field uniform dose (SFUD)...
  54. ncbi Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer
    Laura A Rechner
    Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    Phys Med Biol 57:7117-32. 2012
    ..We conclude that the predicted risk of cancer in the bladder or rectum following proton arc therapy for prostate cancer is either less than or approximately equal to the risk following VMAT, depending on which risk model is applied...
  55. ncbi Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy
    Landon S Wootton
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Appl Clin Med Phys 13:3945. 2012
    ..The cross-sectional area of trapped gas did not differ between the two groups. Thus gas-release balloon can effectively release gas, and may be able to improve clinical workflow by reducing the need for catheterization...
  56. ncbi A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties
    Peter C Park
    Medical Physics Program, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, TX, USA
    Int J Radiat Oncol Biol Phys 82:e329-36. 2012
    ....
  57. ncbi Reducing metal artifacts in cone-beam CT images by preprocessing projection data
    Yongbin Zhang
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 67:924-32. 2007
    ..The goal of this study was to develop an effective offline processing technique to minimize the effect...
  58. ncbi Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?
    Philippe E Spiess
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    BJU Int 99:321-5. 2007
    ..To review our experience with the surgical management of lymph node-positive prostate cancer and to determine if there is a benefit to treating such patients with immediate rather than delayed hormonal therapy (HT)...
  59. ncbi Mortality after cure of testicular seminoma
    Gunar K Zagars
    Department of Radiation Oncology, Box 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 22:640-7. 2004
    ..To determine the incidence of potentially treatment-related mortality in long-term survivors of testicular seminoma treated by orchiectomy and radiation therapy (XRT)...
  60. ncbi Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches
    Heng Li
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Appl Clin Med Phys 12:3471. 2011
    ..6% in the IMRT case and 2.1% in the VMAT case. The magnitude of potential dose difference has been quantified and could be used for a quick estimation of dose difference due to couch attenuation in IMRT and VMAT...
  61. ncbi Current results of brachytherapy for soft tissue sarcoma
    Matthew T Ballo
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Curr Opin Oncol 15:313-8. 2003
    ..Although the application of HDR brachytherapy to soft tissue sarcoma is relatively new, it seems to result in a satisfactory local control rate and may replace traditional low-dose-rate techniques...
  62. ncbi Quantitative analysis of beam delivery parameters and treatment process time for proton beam therapy
    Kazumichi Suzuki
    Department of Radiation Physics, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
    Med Phys 38:4329-37. 2011
    ..To evaluate patient census, equipment clinical availability, maximum daily treatment capacity, use factor for major beam delivery parameters, and treatment process time for actual treatments delivered by proton therapy systems...
  63. ncbi An approach to the management of the patient with metastatic bone disease
    Kristy L Weber
    Section of Orthopaedic Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
    Instr Course Lect 53:663-76. 2004
    ..Treatment includes stabilization with the latest prosthetic implants and new devices. Advances in the field of radiation oncology and bisphosphonate use in patients with bone metastasis are other management approaches...
  64. ncbi Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer
    Hoon K Lee
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:355-61. 2003
    ..An alternative position for a surrogate urethra accounting for the difference in the location of the Foley catheter near the base of the prostate at Day 0 and 1 month could be considered in future studies...
  65. ncbi Uncertainties in physical and biological targeting with radiation therapy
    James D Cox
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Rays 28:211-5. 2003
    ..Molecular therapeutic agents enhance the effects of ionizing radiations in murine systems. Clinical trials combining molecular targeting agents with conformal radiation therapy are being initiated...
  66. ncbi Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
    Seungtaek Choi
    Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
    Drug Healthc Patient Saf 3:107-19. 2011
    ..Therefore, it is crucial that the benefits of ADT be weighed against its potential adverse effects before its use...
  67. ncbi Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer
    Charles J Rosser
    Department of Urology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA
    J Urol 168:2001-5. 2002
    ..The PSA bounce phenomenon was not predictive of time to biochemical recurrence...
  68. ncbi In vivo tumor imaging in mice with near-infrared labeled endostatin
    Deborah Citrin
    Imaging and Molecular Therapeutics Section, Radiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA
    Mol Cancer Ther 3:481-8. 2004
    ..5 will migrate from a distant i.p. injection site to a tumor. These data indicate that endostatin-Cy5.5 is appropriate for selectively imaging tumors in uninjured experimental animals...
  69. ncbi A 12-year experience using the Brown two-portal endoscopic procedure of transverse carpal ligament release in 14,722 patients: defining a new paradigm in the treatment of carpal tunnel syndrome
    Christopher L Hankins
    Houston Hand House and the Hand Center, Texas 77292, USA
    Plast Reconstr Surg 120:1911-21. 2007
    ....